LBO — PARKVIEW MEDICAL CENTER
IRR: 24.3% | MOIC: 2.97x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
24.3%
IRR
2.97x
MOIC
$219.8M
Entry EV
$439.6M
Exit EV
$113.1M
Equity Invested
Sources & Uses
S&UTotal · $219.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $85.4M | 38.8% | |
| Sub Debt | $21.3M | 9.7% | |
| Equity | $113.1M | 51.5% | |
| Enterprise Value | $213.4M | 97.1% | |
| Transaction Fees | $6.4M | 2.9% | |
| Total Uses | $219.8M | 100.0% |
Interpretation
INTAt 2.97x MOIC and 24.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $41.9M |
| Exit Ev | $439.6M |
| Net Debt At Exit | $103.3M |
| Equity At Exit | $336.4M |
| Equity Invested | $113.1M |
| Total Value Created | $223.2M |
| Value From Growth | $215.6M |
| Value From Multiple | $10.7M |
| Value From Deleveraging | $3.4M |